Rare Locations of Plasma Cell Tumour: A Single-Centre Experience

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Observational analysis elucidates incidence of extramedullary disease in multiple myeloma, suggesting poor prognosis with vertebral involvement.

Extramedullary involvement leads to a poor prognosis, particularly with vertebral fractures complicating treatment.
Incidence of extramedullary disease in newly diagnosed multiple myeloma patients ranges from 0.5% to 4.5%.
Retrospective studies provide the primary data on therapeutic responses, underscoring a need for further prospective trials.
This study focuses on paravertebral plasma cell tumours and the associated clinical responses following induction therapy.

Vladimir et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis elucidates incidence of extramedullary disease in multiple myeloma, suggesting poor prognosis with vertebral involvement.

Extramedullary involvement leads to a poor prognosis, particularly with vertebral fractures complicating treatment.
Incidence of extramedullary disease in newly diagnosed multiple myeloma patients ranges from 0.5% to 4.5%.
Retrospective studies provide the primary data on therapeutic responses, underscoring a need for further prospective trials.
This study focuses on paravertebral plasma cell tumours and the associated clinical responses following induction therapy.

Vladimir et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark